Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases.
Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases.
复制标题
DOI:
10.1186/alzrt5
复制
发表时间:
2009-10-12
期刊:
影响因子:
--
通讯作者:
Miller VM
中科院分区:
文献类型:
--
作者:
Golde TE;Miller VM
Alzheimer's disease (AD) and a host of other neurodegenerative central nervous system (CNS) proteinopathies are characterized by the accumulation of misfolded protein aggregates. Simplistically, these aggregates can be divided into smaller, soluble, oligomeric and larger, less-soluble or insoluble, fibrillar forms. Perhaps the major ongoing debate in the neurodegenerative disease field is whether the smaller oligomeric or larger fibrillar aggregates are the primary neurotoxin. Herein, we propose an integrative hypothesis that provides new insights into how a variety of misfolded protein aggregates can result in neurodegeneration. We introduce the concept that a wide range of highly stable misfolded protein aggregates in AD and other neurodegenerative proteinopathies are recognized as non-self and chronically activate the innate immune system. This pro-inflammatory state leads to physiological senescence of CNS cells. Once CNS cells undergo physiological senescence, they secrete a variety of pro-inflammatory molecules. Thus, the senescence of cells, which was initially triggered by inflammatory stimuli, becomes a self-reinforcing stimulus for further inflammation and senescence. Ultimately, senescent CNS cells become functionally impaired and eventually die, and this neurodegeneration leads to brain organ failure. This integrative hypothesis, which we will refer to as the proteinopathy-induced senescent cell hypothesis of AD and other neurodegenerative diseases, links CNS proteinopathies to inflammation, physiological senescence, cellular dysfunction, and ultimately neurodegeneration. Future studies characterizing the senescent phenotype of CNS cells in AD and other neurodegenerative diseases will test the validity of this hypothesis. The implications of CNS senescence as a contributing factor to the neurodegenerative cascade and its implications for therapy are discussed.
登录
查看更多内容
影响因子:
7.7
作者:
Augert, Arnaud;Payre, Christine;Bernard, David
通讯作者:
Bernard, David
影响因子:
82.9
作者:
Backskai, BJ;Kajdasz, ST;Hyman, BT
通讯作者:
Hyman, BT
DOI:
10.1158/1541-7786.mcr-08-0062
发表时间:
2008-07
期刊:
Molecular cancer research : MCR
影响因子:
--
作者:
Coppe JP;Boysen M;Sun CH;Wong BJ;Kang MK;Park NH;Desprez PY;Campisi J;Krtolica A
通讯作者:
Krtolica A
影响因子:
5.5
作者:
Bitan, G;Fradinger, EA;Teplow, DB
通讯作者:
Teplow, DB
影响因子:
5.3
作者:
Bolmont, Tristan;Haiss, Florent;Calhoun, Michael E.
通讯作者:
Calhoun, Michael E.